Phosphate Binders


  • Aluminium Hydroxide (Alucaps, Basaljel)
  • Calcium Carbonate (Calcichew, Titralac) (see Calcium Carbonate)
  • Calcium Acetate (Lenal Ace, PhosLo) (see Calcium Acetate)
  • Lanthanum Carbonate (Fosrenol) (see Lanthanum Carbonate)
  • Sevelamer (Renagel, Renvela) (see Sevelamer)
  • Calcium Acetate/Magnesium Carbonate (Osvaren, Lenal Ace, Renepho)


  • K/DOQI clinical practice guidelines for nutrition in chronic kidney failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6)(suppl 2):S17–S104
  • The dialysis outcomes and practice patterns study (DOPPS): An international hemodialysis study. Kidney Int. 2000;57(suppl 74):S74–S81
  • Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238–2245
  • Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial. 2003;16(3):186–188
  • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Dis. 2003;42(4):S1–S201
  • Hidden phosphorus: where do we go from here? J Ren Nutr. 2007;17(4):e31–e36
  • Is controlling phosphorous by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease. Am J Clin Nutr. 2008;88:1511–1518
  • Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52(3):519–530
  • Understanding sources of dietary phosphorous in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:519–530
  • Use of phosphate-binding agents is associated with lower risk of mortality. Kidney Int. Published online 3 July 2013; doi:10.1038/ki.2013.185 [MEDLINE]